Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.67
+0.09 (1.61%)
At close: Apr 28, 2026, 4:00 PM EDT
5.78
+0.11 (1.94%)
After-hours: Apr 28, 2026, 7:20 PM EDT
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bausch Health Companies stock have an average target of 8.00, with a low estimate of 7.00 and a high estimate of 9.00. The average target predicts an increase of 41.09% from the current stock price of 5.67.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Bausch Health Companies stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 4 | 3 | 3 | 3 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +58.73% | Apr 27, 2026 |
| Barclays | Barclays | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +23.46% | Feb 25, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +41.09% | Jan 7, 2026 |
| Barclays | Barclays | Hold Initiates $8 | Hold | Initiates | $8 | +41.09% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $8.5 → $10 | Hold | Maintains | $8.5 → $10 | +76.37% | May 2, 2025 |
Financial Forecast
Revenue This Year
10.74B
from 10.27B
Increased by 4.61%
Revenue Next Year
10.73B
from 10.74B
Decreased by -0.10%
EPS This Year
4.59
from 0.42
Increased by 992.96%
EPS Next Year
4.32
from 4.59
Decreased by -6.00%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 11.3B | 11.4B | |||||
| Avg | 10.7B | 10.7B | |||||
| Low | 10.3B | 10.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 9.6% | 5.7% | |||||
| Avg | 4.6% | -0.1% | |||||
| Low | 0.0% | -6.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 5.00 | 5.01 | |||||
| Avg | 4.59 | 4.32 | |||||
| Low | 3.97 | 3.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 1,090.0% | 9.1% | |||||
| Avg | 993.0% | -6.0% | |||||
| Low | 845.0% | -15.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.